Pacira BioSciences Inc
PCRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$970.39M
Close$
$58.75
130.1% upside
Current Fair Value
130.1% upsideUndervalued by 130.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $970.39 Million |
|---|---|
| Enterprise Value | $1.18 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 0.27 |
| Outstanding Shares | 39,462,000 |
Return
| Return on Equity | 6.94% |
|---|---|
| Return on Assets | 3.75% |
| Return on Invested Capital | 1.96% |
Valuation & Multiples
| P/E Ratio | 70.07 |
|---|---|
| PEG | -35.75 |
| Price to Sales | 1.42 |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 1.58 |
| Enterprise Value to EBIT | 53.42 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.65
Average shareholder expectationRevenue Estimate
$191.06 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.76
Average shareholder expectationRevenue Estimate
$181.76 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2693▼ 34.20% |
|---|---|
| Total Calls | 32,300▲ 53.08% |
| Total Puts | 8,700▼ 32.56% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 113.39%▲ 10.82% |
|---|---|
| Total Invested | $1.19B▲ 20.84% |
| Investors Holding | 255▲ 12.00% |
ESG Score
No data